Wyeth Loses 2nd Prempro Trial; Jury Awards $3M

Law360, New York (February 20, 2007, 12:00 AM EST) -- Wyeth Pharmaceuticals has lost a second trial in Philadelphia over the controversial hormone replacement therapy, Prempro, with a jury awarding a breast cancer sufferer and her husband $3 million.

After a five-week hearing, the nine-member jury found that Prempro, a drug used by millions of post-menopausal woman, was responsible for Jennie Nelson’s cancer and that Wyeth failed to sufficiently warn users of the risks.

It is the second time a Philadelphia jury has returned a verdict in favor of a plaintiff against Wyeth's Prempro. Last month...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.